Search results
Sushi chef from Michigan wins coveted James Beard Award
MLive.com· 2 hours agoSato was nominated against Vinnie Cimino of Cordella in Cleveland, Jose Salazar of Mita’s in...
Lula Cafe is Chicago’s sole James Beard Restaurant and Chef award winner for 2024
Chicago Tribune· 5 hours agoBeard Restaurant and Chef awards ceremony held at the Lyric Opera House Monday. For almost a decade,...
Nvidia Just Completed a 10-for-1 Stock Split. Here's What to Look for Next.
The Motley Fool via AOL· 20 hours agoJohn Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley...
What Today's Stock Split Means for Nvidia (and You)
Motley Fool via Yahoo Finance· 4 days agoThe Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*. *Stock Advisor returns as of June 3, 2024 Adria Cimino has no...
Here's What Happened After Nvidia's Last 3 Stock Splits (and What That Means for the Stock Today)
Motley Fool via Yahoo Finance· 2 days agoThe Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*. *Stock Advisor...
Why Is Everyone Talking About Nvidia's Stock Split?
Motley Fool via Yahoo Finance· 21 hours agoThe Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*. *Stock Advisor returns as of June 3, 2024 Adria Cimino has no...
Southington bar to hold fundraiser for TFC Aaron Pelletier’s family
FOX61· 5 days ago“I'm donating 15% of our sales for that night from 5 p.m. to 9 p.m. and then we're also doing a...
Nvidia's Stock Split Happens on June 7. Here's What to Expect.
The Motley Fool via AOL· 7 days agoThe Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*. *Stock Advisor...
Southington continues to come together for fallen TFC Pelletier
Eyewitness News 3 Hartford· 4 days agoPelletier was killed by a hit-and-run driver a week ago. The sudden death of Pelletier hit this...
Is This Trend a Threat to Eli Lilly's Weight Loss Drug Dominance?
Motley Fool via Yahoo Finance· 4 days agoAll of this means that, if you're a Lilly investor, the next time you hear about a biotech company...